Related Experiment Videos
Clindamycin and metronidazole
1Department of Community Health, Tufts University School of Medicine, Boston, Massachusetts, USA.
The Medical Clinics of North America
|July 1, 1995
Summary
Metronidazole is a bactericidal antibiotic effective against anaerobes and parasites, with good tissue penetration and few side effects. Its low resistance rates and expanding clinical uses make it a valuable antimicrobial agent.
Area of Science:
- Pharmacology
- Microbiology
- Infectious Diseases
Background:
- Metronidazole is a bactericidal antibiotic with established efficacy against anaerobic bacteria and protozoa.
- The drug exhibits favorable pharmacokinetic properties, including high bioavailability and excellent tissue penetration, reaching sites like the cerebrospinal fluid and brain abscesses.
- It is generally well-tolerated, with a low incidence of adverse effects.
Purpose of the Study:
- To review the properties and clinical applications of metronidazole.
- To highlight its effectiveness against anaerobic infections and parasitic diseases.
- To discuss its expanding role in various medical conditions.
Main Methods:
- Literature review of metronidazole's pharmacological and clinical data.
- Analysis of antimicrobial susceptibility patterns, particularly for anaerobic organisms.
- Examination of clinical case studies and therapeutic guidelines.
Main Results:
- Metronidazole demonstrates potent bactericidal activity against a broad spectrum of anaerobes, including the B. fragilis group.
- Antimicrobial resistance to metronidazole among target pathogens remains low.
- The drug's penetration into critical sites like the central nervous system is a key therapeutic advantage.
Conclusions:
- Metronidazole is a reliable antibiotic for treating anaerobic and certain parasitic infections.
- Its favorable safety profile and low resistance rates support its continued clinical use.
- Ongoing research is defining its role in complex conditions such as Crohn's disease and H. pylori infections.